Stifel Initiates Coverage of Eupraxia Pharmaceuticals (EPRX) with Buy Recommendation
22/5 02:02
Fintel reports that on May 21, 2026, Stifel initiated coverage of Eupraxia Pharmaceuticals (NasdaqCM:EPRX) with a Buy recommendation. Analyst Price Forecast Suggests 89.83% Upside...